Grammer, AC, MM Ryals, MD Catalina and PE Lipsky.  Repositioning drugs for SLE. Systemic Lupus Erythematosus 2016: 567-573.

Lipsky PE, Ryals M, Grammer AC. A Novel Strategy to Identify and Evaluate Approved Drugs & Treatments for Repositioning as Therapies for Systemic Lupus Erythematosus (SLE). American College of Rheumatology 2014, A6 74.

A comprehensive approach to identify approved drugs & treatments for repositioning as therapies for systemic lupus erythematosus.
Grammer AC et al. Arthritis Research & Therapy. 2014

Increased frequency of a unique spleen tyrosine kinase (Syk) bright memory B-cell population in systemic lupus erythematosus.
Fleischer SJ, et al. Arthritis Rheumatol. 2014

Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus.
Wu XN, et al. Sci Transl Med. 2014

Response to D.M. Marcus’s comment on the TRIFRA study (comparison of Tripterygium wilfordii Hook F vs methotrexate in the treatment of active rheumatoid arthritis).
Ann Rheum Dis. 2014 Sep

TwHF versus methotrexate in the treatment of rheumatoid arthritis: response to Landewe’s comment on the TRIFRA study.
Ann Rheum Dis. 2014 Oct

The TRIFRA trial: efforts employed to minimise expectation bias.
Ann Rheum Dis. 2014 Nov

Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial.
Lv QW, et al. Ann Rheum Dis. 2014

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.
Lipsky PE, et al. Arthritis Res Ther. 2014

Tissue distribution and dependence of responsiveness of human antigen-specific memory B cells.
Giesecke C, et al. J Immunol. 2014

B cells: depletion or functional modulation in rheumatic diseases.
Dörner T, et al. Curr Opin Rheumatol. 2014

SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature.
Becker AM, et al. PLoS One. 2013

miR-142-3p is involved in CD25+ CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant.
Zhou Q, et al. J Immunol. 2013

Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus.
Shirota Y, et al. Ann Rheum Dis. 2013

Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus.
Lugar PL, et al. PLoS One. 2012

Splenic proliferative lymphoid nodules distinct from germinal centers are sites of autoantigen stimulation in immune thrombocytopenia.
Daridon C, et al. Blood. 2012

Aberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activity.
Li Y, et al. Arthritis Res Ther. 2012